Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...

During Monday's trading session, shares of a research-based Global Pharmaceutical and Biotech company surged nearly 5.3 ...

A Delaware federal judge has ruled that Novartis cannot prevent MSN Pharmaceuticals from introducing a generic version of its ...

Pharma company Wockhardt stated in a regulatory filing on Friday that it will exit from the US generic drugs market.

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...

Ozempic, which is prescribed for diabetes, and Wegovy, prescribed for weight loss, both contain the active ingredient ...

Wockhardt Ltd on July 11 said it has decided to exit US generic pharmaceutical segment to unlock capital for high-impact ...